Scilex Holding Company header image

Scilex Holding Company

SCLX

Equity

ISIN null / Valor 123144552

NASDAQ (2026-03-23)
USD 7.35-2.26%

Scilex Holding Company
UMushroom community rating:

star star star star star
4.43 7 votes No rating yet
NegativeNeutralPositive

About company

Scilex Holding Company, listed on Nasdaq as SCLX, is a revenue-generating company that specializes in acquiring, developing, and commercializing non-opioid pain management products for both acute and chronic pain. The company aims to establish itself as a global leader in pain management while adhering to social, environmental, economic, and ethical principles in the development of pharmaceutical products that enhance the quality of life. Scilex Holding Company owns subsidiaries such as Scilex Pharmaceuticals and Semnur Pharmaceuticals, which are integral to its operations in the pharmaceutical industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-25.0%1Y
-97.2%3Y
%5Y

Performance

128%1Y
124%3Y
133%5Y

Volatility

Market cap

51 M

Market cap (USD)

Daily traded volume (Shares)

33,606

Daily traded volume (Shares)

1 day high/low

0.4752 / 0.388

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.43

7 votes
Performance:
starstarstarstarstar
4.14
Innovation:
starstarstarstarstar
4.57
Society:
starstarstarstarstar
4.86
Nature:
starstarstarstarstar
4.71
Lukas Mykhnenko
United Kingdom, 08 Nov 2025
star star star star star
promising
Aaditya Sharma
United Kingdom, 06 Nov 2025
star star star star star
Healthcare is a good sector play
Lukas Mykhnenko
United Kingdom, 05 Nov 2025
star star star star star
promising

EQUITIES OF THE SAME SECTOR

Dexcom Inc
Dexcom Inc Dexcom Inc Valor: 2107726
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.51%USD 65.94
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.01%USD 227.08
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.00%USD 74.46
NovoCure Limited
NovoCure Limited NovoCure Limited Valor: 29570025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 11.82
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%USD 27.93
Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp Integra Lifesciences Holdings Corp Valor: 912247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.48%USD 9.43
ICU Medical Inc
ICU Medical Inc ICU Medical Inc Valor: 940704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.65%USD 129.93
CRISPR Therapeutics Ltd
CRISPR Therapeutics Ltd CRISPR Therapeutics Ltd Valor: 33408113
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.38%USD 46.88
Merit Medical Systems Inc
Merit Medical Systems Inc Merit Medical Systems Inc Valor: 951136
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.13%USD 68.13
Lantheus Holdings Inc
Lantheus Holdings Inc Lantheus Holdings Inc Valor: 24784644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%USD 75.73